• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Jul31
Sage Therap released FY2025 Q2 earnings on July 30 (EST), actual revenue USD 31.66 M (forecast USD 16.73 M), actual EPS USD -0.793 (forecast USD -0.9521)
03:00
Jul11
Halper Sadeh Investigating Fairness of Proposed Sage Therapeutics Acquisition
11:51
Jul1
Sage Therapeutics Acquired by Supernus Pharmaceuticals and Laying Off Staff
14:48
Jun17
Truist Financial Raises Sage Therapeutics Target Price to $9
14:58
Halper Sadeh LLC Investigates Sage Therapeutics
01:23
Jun4
Merrill Lynch Cut Its Holdings in Sage Therapeutics
07:04

Schedules & Filings

Schedules
Filings
Jul30
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 31.66 M, Net Income -49.65 M, EPS -0.793

Apr29
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 14.06 M, Net Income -62.21 M, EPS -1.0057

Feb11
Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 12.82 M, Net Income -95.78 M, EPS -1.5633

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ATPC
0.1491
+119.26%
+0.081
MIGI
12.150
+81.35%
+5.530
PETS
3.150
+77.97%
+1.380
AXIL
8.205
+63.45%
+3.185
BEAT
2.400
+54.84%
+0.851
BTTC
5.060
+52.64%
+1.745
DHIL
170.170
+44.85%
+52.690
GEMG
8.860
+39.23%
+2.497
PL
17.650
+36.40%
+4.705
SMX
196.820
+34.53%
+50.520
View More